[Federal Register Volume 85, Number 12 (Friday, January 17, 2020)]
[Notices]
[Page 3077]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00661]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-573]
Importer of Controlled Substances Application: S&B Pharma, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before February 18, 2020.
Such persons may also file a written request for a hearing on the
application on or before February 18, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on November 18, 2019, S&B Pharma, Inc., dba: Norac
Pharma, 405 South Motor Avenue, Azusa, California 91702-3232 applied to
be registered as an importer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Tapentadol............................ 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
bulk for the manufacture of controlled substances for distribution to
its customers.
Dated: December 19, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-00661 Filed 1-16-20; 8:45 am]
BILLING CODE 4410-09-P